Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) — Defensive Interval Ratio
Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) has a Defensive Interval Ratio of 54 days as of June 2025. Defensive assets of ILA3.02 Million (cash ILA-, short-term investments ILA-, receivables ILA3.02 Million) cover 54 days of daily cash needs of ILA55.88K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Tikun Olam Cannbit Pharmaceuticals Ltd Defensive Interval Ratio (2017–2024)
This chart shows how Tikun Olam Cannbit Pharmaceuticals Ltd's Defensive Interval Ratio has evolved across 8 annual periods from 2017 to 2024. As of June 2025, the ratio stands at 54 days, meaning defensive assets of ILA3.02 Million can fund 54 days of operations without new revenue. For the complete balance sheet picture, see TKUN total asset value.
Annual Defensive Interval Ratio for Tikun Olam Cannbit Pharmaceuticals Ltd (2017–2024)
The table below presents the year-by-year Defensive Interval Ratio for Tikun Olam Cannbit Pharmaceuticals Ltd from 2017 to 2024, covering 8 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See TKUN working capital ratio to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (ILA) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 72 days | ILA3.92 Million | ILA54.63K/day | ILA- | ILA- | ▼ -2 days |
| 2023 | 74 days | ILA5.72 Million | ILA77.62K/day | ILA- | ILA- | ▼ -123 days |
| 2022 | 196 days | ILA14.64 Million | ILA74.55K/day | ILA- | ILA- | ▲ +42 days |
| 2021 | 154 days | ILA9.71 Million | ILA62.94K/day | ILA- | ILA- | ▲ +72 days |
| 2020 | 82 days | ILA5.96 Million | ILA72.40K/day | ILA- | ILA- | ▲ +30 days |
| 2019 | 52 days | ILA3.18 Million | ILA60.93K/day | ILA- | ILA- | ▼ -58 days |
| 2018 | 110 days | ILA517.00K | ILA4.70K/day | ILA- | ILA- | ▼ -30 days |
| 2017 | 140 days | ILA18.00K | ILA128.77/day | ILA- | ILA- | — |